The long term follow up of surgery in normal tension glaucoma is presented. Any investigation of the effects of treatment on the rate or type of visual field progression must take into account the inherent variability of response (inter and intratest) that exists within each of us. The simplest way to overcome this variability is to treat one eye and measure the response against the untreated eye. The treatment options that avoid a potential effect on'the contralateral eye are limited. Fistulising surgery to one eye minimises the risk of a crossover effect. We report on the long term results of surgery to one eye in a group of patients with bilateral progressive normal tension glaucoma.
mm Hg in the non-surgery group. The percentage fall in IOP was 31-39% in the surgery group and 0.83% in the non-surgery group.
One patient received systemic 3 blockers for a period during the study. Table 1 shows the clinical characteristics. From year 2 there was a progressive divergence in the visual field performance of the eyes in operated and non-operated groups. A greater number of deteriorating locations existed in the unoperated group and they did so at a faster rate (Figures 1-5 , Tables 2 and 3 ).
Discussion
This paper has shown that in a small group of patients with progressive normal tension glaucoma fistulising surgery to one eye was associated with fewer progressing retinal locations, and that those locations that did progress did so at a slower rate. As this has implications for the management of this condition a number of points need clarification first. These include:
(a) were the study patients typical for all normal tension glaucomas? The PROGRESSOR program only analyses significant regression slopes, therefore variability has already been taken into account. By insisting on two or more consecutive significant slopes (which, in this study were 3-4/12 apart), the effect of a single spurious result is minimised. Linear regression analysis was chosen because it gave the best fit on the decay of retinal sensitivity in untreated normal tension glaucoma patients.8 A minimal rate of decay 1 The results presented refer only to a small Follow up (year) Figure 4 Visualfield loss (no of negative regression slopes) in normal tension glaucoma. The difference in the number ofprogressing locations between operated and unoperated eyes. cohort of patients. It would be unreasonable to expect every patient to behave in the same way. In her analysis of a large group of patients with normal tension glaucoma, Gjeissen subdivided her patients into several subtypes and considered whether the behaviour could be different between groups.10 If that was the case then some of her subtypes could be expected to respond better to IOP lowering then others. Patients at Moorfields Eye Hospital show a striking range in the rate of deterioration of points in their visual field. Some patients over years of follow up appear to deteriorate slowly, if at all on kinetic testing1 as well as static testing. This apparent lack of change agrees well with and others.12 13 Clearly, surgical treatment should not be offered to patients whose visual fields appear stable.
The eye selected for surgery was considered to have the more severe visual field defect. It could be argued that this prejudiced the results against the operated eye in view of the findings of others that the response to treatment (for high tension glaucoma) is more easily detected in eyes with 'early' disease (less severe visual field defects14 15). Conversely, it could be argued that with fewer normal locations there was less change of detecting progression. Analysis of individual locations showed that significant negative slopes could be identified even if the 'start defect' was 20 dB loss. As progression often occurs around the sides of an absolute defect then the larger the initial defect the greater the chance of progression being detected. Follow up (year) Figure S The difference in the rate ofloss (dB/year) in the operated and unoperated eyes from years 2-6.
The case for IOP playing a significant role in the progression of visual field defects in normal tension glaucoma was An earlier analysis of changes occurring in this cohort 2 years after surgery could not detect differences between the operated and nonoperated eyes. The effects of IOP lowering may have occurred by that time but could not be detected. This may be because the sensitivity of the field analysis depends on the number of points, and that any differences present at 2 years after surgery could not be detected using only five to six tests. More frequent perimetry may well have allowed earlier detection of a difference than was found in our patients. Alternatively a lag period may exist before changes in rate of loss occur after alterations in treatment.
Conclusion
From the evidence presented we suggest that eyes with progressive normal tension glaucoma may have the rate of their visual field loss slowed or halted by long term lowering of the IOP to subnormal levels. In the absence of universally applicable medical methods to achieve these target pressures we consider that this will involve fistulising surgery. In many eyes with NTG these target pressures will only be achieved with the use of antiproliferative drugs. Because many years may pass before progression occurs, or can be detected we do not consider that surgery should be performed on making the diagnosis, but only when unequivocal progression has occurred.
